Evaluation of red blood cell labelling methods based on a statistical model for red blood cell survival

Journal of Theoretical Biology

Volumn 291, Issue 1, 2011, Pages 88-98

  Korell, Julia ^a   Coulter, Carolyn V ^a   Duffull, Stephen B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cohort labelling; Heavy nitrogen; Optimal design; Radioactive chromium; Random labelling

Indexed keywords

BLOOD; CELL ORGANELLE; CHROMIUM; COHORT ANALYSIS; COMPARATIVE STUDY; DESIGN; METHODOLOGY; NITROGEN; OPTIMIZATION; PARAMETERIZATION; PHYSIOLOGICAL RESPONSE; RADIOACTIVITY;

ARTICLE; BLOOD SAMPLING; CELL LABELING; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE; INTERMETHOD COMPARISON; ISOTOPE LABELING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STATISTICAL MODEL; SURVIVAL TIME;

CELL SURVIVAL; CHROMIUM RADIOISOTOPES; ERYTHROCYTE AGING; ERYTHROCYTES; HUMANS; MODELS, STATISTICAL; NITROGEN ISOTOPES;

EID: 80053451467     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2011.09.016     Document Type: Article

References (43)

1. Amatuzio D., Evans R. Isotope curves in red blood cell studies. Nature 1953, 171:797-798.
2. Atkinson A., Donev A. Optimum Experimental Designs 1992, Oxford University Press, Oxford, UK.
3. Audi G., Bersillon O., Blachot J., Wapstra A. The NUBASE evaluation of nuclear and decay properties. Nucl. Phys. A 1997, 624:1-124.
4. Ayres R., Shaw J., Mills C., Coleman R., Neuberger J. A 51Cr release cytotoxicity assay for use with human intrahepatic biliary epithelial cells. J. Immunol. Methods 1991, 141:117-122.
5. Bebbington M., Lai C., Zitikis R. Modeling human mortality using mixtures of bathtub shaped failure distributions. J. Theor. Biol. 2007, 245:528-538.
6. Berlin N., Waldmann T., Weissmann S. Life span of red blood cell. Physiol. Rev. 1959, 39:577-616.
7. Bosman G., Willekens F., Werre J. Erythrocyte aging: a more than superficial resemblance to apoptosis?. Cell Physiol. Biochem. 2005, 16:1-8.
8. Bosman G., Werre J., Willekens F., Novotny V. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus. Med. 2008, 18:335-347.
9. Brouillard R. Measurement of red blood cell life-span. JAMA 1974, 230:1304-1305.
10. Cavill I. Red cell lifespan estimation by 51Cr labelling. Br. J. Haematol. 2002, 117:997.
11. Cline M., Berlin N. The red cell chromium elution rate in patients with some hematologic diseases. Blood 1963, 21:63-69.
12. Corbett G., O'flaherty E., Liang J., Throop L., Finley B., Kerger B. In vitro reduction kinetics of hexavalent chromium in human blood. Environ. Res. 1998, 78:7-11.
13. Currie L. Limits for qualitative detection and quantitative determination. Application to radiochemistry. Anal. Chem. 1968, 40:586-593.
14. Eadie G., Brown I. Analytic review: red blood cell survival studies. Blood 1953, 8:1110-1136.
15. 51 tagging and differential hemolysis. J. Clin. Invest. 1955, 34:629-636.
16. Ebaugh F., Emerson C., Roos J. The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination of red cell survival in vivo. J. Clin. Invest. 1953, 29:1260-1276.
17. Foo L., Duffull S. Methods of robust design of nonlinear models with an application to pharmacokinetics. J. Biopharm. Stat. 2010, 20:886-902.
18. Franco R. The measurement and importance of red cell survival. Am. J. Hematol. 2009, 84:109-114.
19. Freise K., Widness J., Schmidt R., Veng-Pedersen P. Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep. J. Pharmacokinet. Pharmacodyn. 2008, 35:285-323.
20. Freud A., Canfi A., Ben-Hur E. Validity of chromium-51 labelling of human erythrocytes as an assay for their survival after photodynamic therapy in vitro for blood sterilization. Int. J. Radiat. Biol. 1993, 63:651-653.
21. Furne J., Springfield J., Ho S., Levitt M. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J. Lab. Clin. Med. 2003, 142:52-57.
22. 32P) as a label for red cells in man. Br. J. Haematol. 1962, 8:15-27.
23. Garby L., Groth T., Schneider W. Determination of kinetic parameters of red blood cell survival by computer simulation. Comput. Biomed. Res. 1969, 2:229-241.
24. Gifford S., Derganc J., Shevkoplyas S., Yoshida T., Bitensky M. A detailed study of time-dependent changes in human red blood cells: from reticulocyte maturation to erythrocyte senescence. Br. J. Haematol. 2006, 135:395-404.
25. Goldstein D., Little R., Lorenz R., Malone J., Nathan D., Peterson C., Sacks D. Tests of glycemia in diabetes. Diabetes Care 2004, 27:1761-1773.
26. Gray S., Sterling K. The tagging of red cells and plasma proteins with radioactive chromium. J. Clin. Invest. 1950, 29:1604-1613.
27. Greenwalt T. The how and why of exocytic vesicles. Transfusion (Paris) 2006, 46:143-152.
28. 51Cr-labelled red cells. Clin. Sci. 1956, 15:207-218.
29. International Committee for Standardization in Haematology Recommended method for radioisotope red-cell survival studies. Br. J. Haematol. 1980, 45:659-666.
30. Korell J., Coulter C., Duffull S. A statistical model for red blood cell survival. J. Theor. Biol. 2011, 268:39-49.
31. Krishnan S., Dixit N. Estimation of red blood cell lifespan from alveolar carbon monoxide measurements. Transl. Res. 2009, 154:15-17.
32. Mock D., Lankford G., Widness J., Burmeister L., Kahn D., Strauss R. Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion (Paris) 1999, 39:156-162.
33. Ramsay W., Fulton J. A new method for the assay of small amounts of radioactive iron (59Fe). Anal. Biochem. 1964, 8:319-324.
34. Ross J., Chapin M. Effect of storage of citrated blood on the survival of transfused erythrocytes. JAMA 1943, 123:827-829.
35. Shemin D., Rittenberg D. The life span of the human red blood cell. J. Biol. Chem. 1946, 166:627-636.
36. Strocchi A., Schwartz S., Ellefson M., Engel R., Medina A., Levitt M. A simple carbon monoxide breath test to estimate erythrocyte turnover. J. Lab. Clin. Med. 1992, 120:392-399.
37. Suzuki T., Dale G. Biotinylated erythrocytes: in vivo survival and in vitro recovery. Blood 1987, 70:791-795.
38. Szymanski I., Valeri C. Factors influencing chromium elution from labelled red cells in vivo and the effect of elution on red-cell survival measurements. Br. J. Haematol. 1970, 19:397-409.
39. Uehlinger D., Gotch F., Sheiner L. A pharmacodynamic model of erythropoietin therapy for uremic anemia. Clin. Pharmacol. Ther. 1992, 51:76-89.
40. Virtue M., Furne J., Nuttall F., Levitt M. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004, 27:931-935.
41. Werre J., Willekens F., Bosch F., De Haan L., Van Der Vegt S., Van Den Bos A., Bosman G. The red cell revisited - Matters of life and death. Cell Mol. Biol. 2004, 50:139-145.
42. Willekens F., Bosch F., Roerdinkholder-Stoelwinder B., Groenen-Doepp Y., Werre J. Quantification of loss of haemoglobin components from the circulating red blood cell in vivo. Eur. J. Haematol. 1997, 58:246-250.
43. Willekens F., Roerdinkholder-Stoelwinder B., Groenen-Doepp Y., Bos H., Bosman G., Van Den Bos A., Verkleij A., Werre J. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 2003, 101:747-751.